Upcoming Earnings: Q2 '26
Estimated EPS
-$0.17
Estimated Rev
$20.01M
$TELA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.21 up 16.00% YoY • Reported revenue of $19.06M up 2.91% YoY • TELA Bio reiterated full year 2026 revenue growth guidance of at least 8% over full year 2025 and expects second quarter 2026 revenue to be approximately $20M.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.17 | -- | -- | N/A |
Q1 '26 | -$0.18 | -$0.21 | -14.17% | MISSED |
Q4 '25 | -$0.18 | -$0.17 | 4.49% | BEAT |
Q3 '25 | -$0.19 | -$0.19 | 1.52% | BEAT |
Q2 '25 | -$0.18 | -$0.22 | -25.02% | MISSED |